Response Letter to Editor: In Reference to Letter to Viscosuplementation - Rezende MU, Campos GC. Rev Bras Ortop 2012;47(2):160-164
- PMID: 33935328
- PMCID: PMC8075634
- DOI: 10.1055/s-0041-1728705
Response Letter to Editor: In Reference to Letter to Viscosuplementation - Rezende MU, Campos GC. Rev Bras Ortop 2012;47(2):160-164
References
-
- Agerup B, Berg P, Akermark C. Non-animal stabilized hyaluronic acid: a new formulation for the treatment of osteoarthritis. https://idp.springer.com/authorize/casa?redirect_uri=https://link.spring.... BioDrugs. 2005;19(01):23–30. - PubMed
-
- Ågerup B.Polysaccharide gel composition. US PatentPublished online October 27, 1998 [accessed February 8, 2021]. Available from:https://patentimages.storage.googleapis.com/0a/88/88/ec49d4a8dcf930/US58...
-
- Lindqvist U, Tolmachev V, Kairemo K, Aström G, Jonsson E, Lundqvist H. Elimination of stabilised hyaluronan from the knee joint in healthy men. Clin Pharmacokinet. 2002;41(08):603–613. - PubMed
-
- Ågren U M, Tammi R H, Tammi M I. Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture. Free Radic Biol Med. 1997;23(07):996–1001. - PubMed
-
- Kemper F, Gebhardt U, Meng T, Murray C. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice. Curr Med Res Opin. 2005;21(08):1261–1269. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous